FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Dextrose 10% Injection
Status: Currently in Shortage
»Date first posted: 03/01/2022
»Therapeutic Categories: Endocrinology/Metabolism; Gastroenterology; Other; Pediatric

Expand all

B. Braun Medical Inc. (New 03/01/2022)

Company Contact Information:
800-227-2862

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
10% 1000 mL Excel Bag L5200 (NDC 0264-7520-00) Product available
10% 500 mL Excel Bag L5201 (NDC 0264-7520-10) Product available
10% 250 mL Excel Bag L5202 (NDC 0264-7520-20) Product on allocation for contracted customers Other

Baxter Healthcare (Reverified 04/27/2022)

Company Contact Information:
888-229-0001

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
10% Dextrose Injection, 250 mL Viaflex Plastic Container. Product Code 2B0162Q (NDC 0338-0023-02) Available on Allocation Other
10% Dextrose Injection, 500 mL Viaflex Plastic Container. Product Code 2B0163Q (NDC 0338-0023-03) Available on Allocation Other
10% Dextrose Injection, 1000 mL Viaflex Plastic Container. Product Code 2B0164X (NDC 0338-0023-04) Available on Allocation Other

Fresenius Kabi USA, LLC (Reverified 05/04/2022)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
10% Dextrose Injection, Single dose freeflex bag, (100 mg per mL), (25 grams per 250 mL) (NDC 63323-824-74) Backordered. Next release August 2022. Increase in Demand
10% Dextrose Injection, Single dose freeflex bag, (100 mg per mL), (50 grams per 500 mL) (NDC 63323-824-75) Backordered. Next release July 2022. Check wholesalers for inventory. Increase in Demand
10% Dextrose Injection, Single dose freeflex bag, (100 mg per mL), (100 grams per 1,000 mL) (NDC 63323-824-76) Backordered. Next release August 2022. Increase in Demand

ICU Medical, Inc. (Reverified 05/05/2022)

Company Contact Information:
877-946-7747

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
10% Dextrose Injection, USP, 250 mL (Legacy Hospira NDC 0409-7930-02), (ICU Medical NDC 0990-7930-02) Allocation ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Demand increase for the drug
10% Dextrose Injection, USP, 500 mL (Legacy Hospira NDC 0409-7930-03), (ICU Medical NDC 0990-7930-03) Allocation ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Demand increase for the drug
10% Dextrose Injection, USP, 1000 mL (Legacy Hospira NDC 0409-7930-09), (ICU Medical NDC 0990-7930-09) Allocation ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Demand increase for the drug
10% Dextrose Injection, USP, 500 mL (Legacy Hospira NDC 0409-7938-19) (ICU Medical NDC 0990-7938-19) Allocation ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Demand increase for the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English